Skip to main content
. 2022 May 25;16(6):729–744. doi: 10.4162/nrp.2022.16.6.729

Fig. 4. Hepatic protein expression and mRNA levels of inflammatory mediators after the oral administration of L-methionine for 14 days. (A) Hepatic protein expression and mRNA levels of IL-1β. (B) Hepatic protein expressions and mRNA levels of IL-6. (C) Hepatic protein expressions and mRNA levels of iNOS. (D) Hepatic protein expressions and mRNA levels of TNF-α. Values are the means ± SEM (n = 6).

Fig. 4

IL-1β, interleukin-1β; IL-6, interleukin-6; iNOS, inducible nitric oxide synthase; TNF-α, tumor necrotic factor-alpha; C, control; M50, basal diet and administered L-methionine orally at 215.0 mg/kg bw; M62.5, basal diet and administered L-methionine orally at 268.8 mg/kg bw; M75, basal diet and administered L-methionine orally at 322.5 mg/kg bw; M100, basal diet and administered L-methionine orally at 430.0 mg/kg bw.

*P < 0.05, compared with C.